| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.103.1.108 |
| P698 | PubMed publication ID | 11136694 |
| P2093 | author name string | Haskard DO | |
| Miller NE | |||
| Weerasinghe A | |||
| Lerch PG | |||
| Huehns TY | |||
| Stocker C | |||
| Cockerill GW | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| lipoprotein | Q28350 | ||
| interleukins | Q194908 | ||
| P304 | page(s) | 108-112 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation | |
| P478 | volume | 103 |
| Q92598987 | Acute kidney injury in hospitalized patients who underwent percutaneous kidney biopsy for histological diagnosis of their renal disease |
| Q37622061 | An update on the lipid nephrotoxicity hypothesis |
| Q35070590 | ApoE polymorphism is associated with C-reactive protein in low-HDL family members and in normolipidemic subjects. |
| Q24299366 | Apolipoprotein A-IV inhibits experimental colitis |
| Q46371879 | Are cholesterol and depression inversely related? A meta-analysis of the association between two cardiac risk factors |
| Q92107730 | Association between Pretreatment Serum High-density Lipoprotein Cholesterol and Treatment Outcomes in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Treated with Chemoradiotherapy: Findings from a Randomised Trial |
| Q44060081 | Association between high-density lipoprotein and cognitive impairment in the oldest old. |
| Q51374681 | Associations of cholesterol and glucose with cardiovascular dysfunction in black Africans: the SABPA study. |
| Q34095633 | Atorvastatin protects against cerebral ischemia/reperfusion injury through anti-inflammatory and antioxidant effects |
| Q37418039 | BIDIRECTIONAL PROSPECTIVE ASSOCIATIONS OF METABOLIC SYNDROME COMPONENTS WITH DEPRESSION, ANXIETY, AND ANTIDEPRESSANT USE. |
| Q35860029 | Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches |
| Q27000421 | Cardioprotective functions of HDLs |
| Q36419283 | Cardiovascular disease risk reduction by raising HDL cholesterol--current therapies and future opportunities |
| Q36405130 | Cellular cholesterol homeostasis in vascular endothelial cells |
| Q40771209 | Correlation of E-selectin concentrations with carotid intima-media thickness and cardio-metabolic profile of mixed ancestry South Africans: a cross-sectional study |
| Q36401585 | Diabetes mellitus-associated atherosclerosis: mechanisms involved and potential for pharmacological invention |
| Q34743688 | Effect of alcohol on lipids and lipoproteins in relation to atherosclerosis |
| Q36755154 | Effect of plasma lipids and APOE genotype on cognitive decline |
| Q38616803 | Effects of ABCA1 R219K Polymorphism and Serum Lipid Profiles on Mild Cognitive Impairment in Type 2 Diabetes Mellitus |
| Q43939775 | Elevated soluble CD40 ligand is related to the endothelial adhesion molecules in patients with acute coronary syndrome |
| Q43244784 | Endothelial function in subjects with isolated low HDL cholesterol: role of nitric oxide and circulating progenitor cells |
| Q39178456 | Extra-virgin olive oil consumption reduces the age-related decrease in HDL and paraoxonase 1 anti-inflammatory activities |
| Q43826029 | Factors associated with cognitive decline in older adults with type 2 diabetes mellitus during a 6-year observation |
| Q28287747 | GPR109A and vascular inflammation |
| Q46931630 | Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammation |
| Q37257483 | Group III secreted phospholipase A2 transgenic mice spontaneously develop inflammation |
| Q38293467 | HDL and atherothrombotic vascular disease |
| Q36929420 | HDL and endothelial protection. |
| Q37244748 | HDL therapy for cardiovascular diseases: the road to HDL mimetics. |
| Q35062398 | HDL therapy for the acute treatment of atherosclerosis |
| Q28580308 | HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production |
| Q34157008 | High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A. |
| Q55257374 | High-density lipoprotein suppresses tumor necrosis factor alpha production by mycobacteria-infected human macrophages. |
| Q91704844 | High-density lipoproteins during sepsis: from bench to bedside |
| Q35777408 | High-density lipoproteins: multifunctional vanguards of the cardiovascular system |
| Q64239061 | How stress mediators can cumulatively contribute to Alzheimer's disease An allostatic load approach |
| Q34287806 | Inhibition of collar-induced carotid atherosclerosis by recombinant apoA-I cysteine mutants in apoE-deficient mice |
| Q34497101 | Intravenous sphingosylphosphorylcholine protects ischemic and postischemic myocardial tissue in a mouse model of myocardial ischemia/reperfusion injury |
| Q36767859 | Invited commentary: lipoproteins and dementia - is it the apolipoprotein A-I? |
| Q38006731 | LDL-cholesterol versus HDL-cholesterol in the atherosclerotic plaque: inflammatory resolution versus thrombotic chaos |
| Q44205496 | Lack of inhibitory effect of HDL on TNFalpha-induced adhesion molecule expression in human aortic endothelial cells |
| Q34038935 | Low HDL Cholesterol is Associated with Lower Gray Matter Volume in Cognitively Healthy Adults. |
| Q24642517 | Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife: the Whitehall II study |
| Q40432809 | Low HDL levels and the risk of death, sepsis and malignancy |
| Q40139208 | Low high-density lipoprotein cholesterol and particle concentrations are associated with greater levels of endothelial activation markers in Multi-Ethnic Study of Atherosclerosis participants. |
| Q50935578 | Low levels of high-density lipoproteins are associated with acute kidney injury following revascularization for chronic limb ischemia. |
| Q35231847 | Low levels of serum paraoxonase activities are characteristic of metabolic syndrome and may influence the metabolic-syndrome-related risk of coronary artery disease |
| Q56111367 | Low serum high-density lipoprotein cholesterol in childhood is associated with adolescent asthma |
| Q50000262 | Low serum levels of High-Density Lipoprotein cholesterol (HDL-c) as an indicator for the development of severe postpartum depressive symptoms. |
| Q47233931 | Mapping Atheroprotective Functions and Related Proteins/Lipoproteins in Size Fractionated Human Plasma. |
| Q44594446 | Mechanisms of high-density lipoprotein cholesterol effects on the endothelial function in hyperlipemia |
| Q35815450 | Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV-infected children. |
| Q53621412 | Metabolic syndrome aggravates the increased endothelial activation and low-grade inflammation in subjects with familial low HDL. |
| Q37431348 | Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle |
| Q37000084 | New insights into the role of HDL as an anti-inflammatory agent in the prevention of cardiovascular disease |
| Q34572620 | Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I. |
| Q39912505 | Phosphatidylethanol mediates its effects on the vascular endothelial growth factor via HDL receptor in endothelial cells |
| Q35726892 | Polymorphism in apoA1 Influences High-Density Lipoprotein Cholesterol Levels but Is Not a Major Risk Factor of Alzheimer's Disease |
| Q26772786 | Protective Effects of HDL Against Ischemia/Reperfusion Injury |
| Q37807911 | Recombinant high-density lipoprotein formulations |
| Q36693904 | Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study |
| Q97529844 | Relationship between high-density lipoprotein cholesterol levels and endothelial function in women: a cross-sectional study |
| Q37233240 | Relationship between plasma lipids and mild cognitive impairment in the elderly Chinese: a case-control study |
| Q89964000 | Revealing a Novel Landscape of the Association Between Blood Lipid Levels and Alzheimer's Disease: A Meta-Analysis of a Case-Control Study |
| Q47203442 | Serum cholesterol trajectories in the 10 years prior to lymphoma diagnosis. |
| Q45125312 | Serum lipids and hippocampal volume: the link to Alzheimer's disease? |
| Q44336199 | Significance of platelet-activating factor acetylhydrolase in patients with non-insulin-dependent (type 2) diabetes mellitus. |
| Q41037922 | Systemic Hepatic-Damage Index for Predicting the Prognosis of Hepatocellular Carcinoma after Curative Resection |
| Q44241902 | Targeted replacement of mouse apolipoprotein A-I with human ApoA-I or the mutant ApoA-IMilano. Evidence of APOA-IM impaired hepatic secretion. |
| Q40544969 | Targeting of scavenger receptor class B type I by synthetic amphipathic alpha-helical-containing peptides blocks lipopolysaccharide (LPS) uptake and LPS-induced pro-inflammatory cytokine responses in THP-1 monocyte cells |
| Q46921866 | The antiatherogenic and antiinflammatory effect of HDL-associated lysosphingolipids operates via Akt -->NF-kappaB signalling pathways in human vascular endothelial cells |
| Q35566170 | The impact of heparin compounds on cellular inflammatory responses: a construct for future investigation and pharmaceutical development |
| Q46199976 | The impact of long-chain n-3 polyunsaturated fatty acids on human health. |
| Q55340154 | The impact of nontraditional lipid profiles on left ventricular geometric abnormalities in general Chinese population. |
| Q37418412 | The influence of ApoE genotype on the lipid profile and lipoproteins during normal pregnancy in a Southern African population |
| Q37808540 | The proteomic advantage: label-free quantification of proteins expressed in bovine milk during experimentally induced coliform mastitis |
| Q36455889 | The rationale for using apoA-I as a clinical marker of cardiovascular risk |
| Q38151145 | The real role of prediagnostic high-density lipoprotein cholesterol and the cancer risk: a concise review. |
| Q37997004 | The renoprotective actions of peroxisome proliferator-activated receptors agonists in diabetes |
| Q35638053 | The role of cholesterol and statins in Alzheimer's disease |
| Q34730815 | The role of high-density lipoproteins in reducing the risk of vascular diseases, neurogenerative disorders, and cancer |
| Q28085668 | The role of metabolic syndrome in heart failure |
| Q36304186 | Therapeutic approaches to raising plasma HDL-cholesterol levels |
| Q38293492 | Therapeutic potential of HDL in cardioprotection and tissue repair |
| Q37677573 | Vasculoprotective Effects of Apolipoprotein Mimetic Peptides: An Evolving Paradigm In Hdl Therapy (Vascular Disease Prevention, In Press.). |
| Q81772565 | [T cell-dependent monocyte activation, TNFalpha and apolipoprotein A-I in autoimmunity and inflammation] |
Search more.